A new study says more people taking Fosamax (alendronate) might be at risk for developing major problems with their jaws than scientists believed before, according to findings published in the latest ...

Add Yahoo as a preferred source to see more of our stories on Google. If you're one of the 8 million American women with osteoporosis, your doctor has probably talked to you about treatment options to ...

The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...

How would you feel if you were harmed by a medicine you took as prescribed and then learned that the drug company wasn’t liable — even though it knew about the risk and didn’t tell you or your doctor?

> Connecticut has hopped on the investigatory bandwagon, announcing plans to probe Merck and Schering-Plough's marketing of the anticholesterol combo pill Vytorin. Prescriptions for the drug are down ...

NEW YORK Fosamax is the most widely used treatment for osteoporosis, racking up $3 billion in sales last year alone. The drug works by slowing erosion of the bone, and it's proven to reduce the chance ...

Dr. Keith Roach is a physician at Weill Cornell Medical College and New York Presbyterian Hospital. He writes an educational column on infectious diseases, public health and sports medicine. DEAR DR.

Dear Dr. Roach: I am a 71-year-old man who recently had a bone density scan. The test showed I had mild bone loss, and I was told I needed to go on medication. I was prescribed a vitamin D and calcium ...

Fosamax is the most widely used treatment for osteoporosis - racking up three billion dollars in sales last year alone. The drug works by slowing erosion of the bone, and it's proven to reduce the ...